Targeting BRCA2 deficiency with GSK3 inhibitors
<p>BRCA1 and BRCA2 tumour suppressors are essential for homologous recombination-mediated double-strand break repair and replication fork protection. Therefore, BRCA1 and BRCA2 are essential for cell viability. Deactivating mutations in one of these genes lead to genome instability and are ass...
Huvudupphovsman: | Zonderland, G |
---|---|
Övriga upphovsmän: | Tarsounas, M |
Materialtyp: | Lärdomsprov |
Publicerad: |
2017
|
Liknande verk
-
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
av: Tacconi, E, et al.
Publicerad: (2019) -
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
av: Eliana MC Tacconi, et al.
Publicerad: (2019-05-01) -
Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds
av: Zimmer, J, et al.
Publicerad: (2016) -
Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights
av: Ashwin Ragupathi, et al.
Publicerad: (2023-03-01) -
Novel approaches for targeting BRCA2-deficient tumour cells
av: Tacconi, E
Publicerad: (2015)